These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 31908929)

  • 1. Clinical Neurorestorative Therapeutic Guidelines for Spinal Cord Injury (IANR/CANR version 2019).
    Huang H; Young W; Skaper S; Chen L; Moviglia G; Saberi H; Al-Zoubi Z; Sharma HS; Muresanu D; Sharma A; El Masry W; Feng S;
    J Orthop Translat; 2020 Jan; 20():14-24. PubMed ID: 31908929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus of clinical neurorestorative progress in patients with complete chronic spinal cord injury.
    Huang H; Sun T; Chen L; Moviglia G; Chernykh E; von Wild K; Deda H; Kang KS; Kumar A; Jeon SR; Zhang S; Brunelli G; Bohbot A; Soler MD; Li J; Cristante AF; Xi H; Onose G; Kern H; Carraro U; Saberi H; Sharma HS; Sharma A; He X; Muresanu D; Feng S; Otom A; Wang D; Iwatsu K; Lu J; Al-Zoubi A
    Cell Transplant; 2014; 23 Suppl 1():S5-17. PubMed ID: 25302689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017).
    Huang H; Young W; Chen L; Feng S; Zoubi ZMA; Sharma HS; Saberi H; Moviglia GA; He X; Muresanu DF; Sharma A; Otom A; Andrews RJ; Al-Zoubi A; Bryukhovetskiy AS; Chernykh ER; Domańska-Janik K; Jafar E; Johnson WE; Li Y; Li D; Luan Z; Mao G; Shetty AK; Siniscalco D; Skaper S; Sun T; Wang Y; Wiklund L; Xue Q; You SW; Zheng Z; Dimitrijevic MR; Masri WSE; Sanberg PR; Xu Q; Luan G; Chopp M; Cho KS; Zhou XF; Wu P; Liu K; Mobasheri H; Ohtori S; Tanaka H; Han F; Feng Y; Zhang S; Lu Y; Zhang Z; Rao Y; Tang Z; Xi H; Wu L; Shen S; Xue M; Xiang G; Guo X; Yang X; Hao Y; Hu Y; Li J; Ao Q; Wang B; Zhang Z; Lu M; Li T
    Cell Transplant; 2018 Feb; 27(2):310-324. PubMed ID: 29637817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurorestoratology: New Advances in Clinical Therapy.
    Huang H; Sharma HS; Chen L; Chen D
    CNS Neurol Disord Drug Targets; 2023; 22(7):1031-1038. PubMed ID: 36043718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury.
    Huang H; Xi H; Chen L; Zhang F; Liu Y
    Cell Transplant; 2012; 21 Suppl 1():S23-31. PubMed ID: 22507677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.
    Derakhshanrad N; Saberi H; Yekaninejad MS; Joghataei MT; Sheikhrezaei A
    J Neurosurg Spine; 2018 Jul; 29(1):97-107. PubMed ID: 29701561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Clinical Practice Guideline on the Timing of Surgical Decompression and Hemodynamic Management of Acute Spinal Cord Injury and the Prevention, Diagnosis, and Management of Intraoperative Spinal Cord Injury: Introduction, Rationale, and Scope.
    Tetreault LA; Kwon BK; Evaniew N; Alvi MA; Skelly AC; Fehlings MG
    Global Spine J; 2024 Mar; 14(3_suppl):10S-24S. PubMed ID: 38632715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Neurorestoratology-Current status and future developments.
    Huang H; Ramon-Cueto A; El Masri W; Moviglia GA; Saberi H; Sharma HS; Otom A; Chen L; Siniscalco D; Sarnowska A
    Int Rev Neurobiol; 2023; 171():207-239. PubMed ID: 37783556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of neurological and functional outcomes after administration of granulocyte-colony-stimulating factor in motor-complete versus motor-incomplete postrehabilitated, chronic spinal cord injuries: a phase I/II study.
    Saberi H; Derakhshanrad N; Yekaninejad MS
    Cell Transplant; 2014; 23 Suppl 1():S19-23. PubMed ID: 25302604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 2020 Yearbook of Neurorestoratology.
    Huang H; Chen L; Chopp M; Young W; Robert Bach J; He X; Sarnowaska A; Xue M; Chunhua Zhao R; Shetty A; Siniscalco D; Guo X; Khoshnevisan A; Hawamdeh Z
    J Neurorestoratology; 2021 Mar; 9(1):1-12. PubMed ID: 37387779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovering Voiding and Sex Function in a Patient with Chronic Complete Spinal Cord Injury by Olfactory Ensheathing Cell Transplantation.
    Chen D; Xi H; Tan K; Huang H
    Case Rep Neurol Med; 2022; 2022():9496652. PubMed ID: 35846867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurorestorative interventions involving bioelectronic implants after spinal cord injury.
    Cho N; Squair JW; Bloch J; Courtine G
    Bioelectron Med; 2019; 5():10. PubMed ID: 32232100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard recommendations for the application of Chinese clinical cell therapy for neurorestoration (2012).
    ;
    Cell Transplant; 2013; 22 Suppl 1():S5-10. PubMed ID: 24044360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time is spine: a review of translational advances in spinal cord injury.
    Badhiwala JH; Ahuja CS; Fehlings MG
    J Neurosurg Spine; 2018 Dec; 30(1):1-18. PubMed ID: 30611186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of olfactory ensheathing cell transplantation in six patients with chronic complete spinal cord injury.
    Rao Y; Zhu W; Guo Y; Jia C; Qi R; Qiao R; Cao D; Zhang H; Cui Z; Yang L; Wang Y
    Cell Transplant; 2013; 22 Suppl 1():S21-5. PubMed ID: 23992752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Clinical Practice Guideline for the Management of Patients With Acute Spinal Cord Injury: Recommendations on the Type and Timing of Rehabilitation.
    Fehlings MG; Tetreault LA; Aarabi B; Anderson P; Arnold PM; Brodke DS; Chiba K; Dettori JR; Furlan JC; Harrop JS; Hawryluk G; Holly LT; Howley S; Jeji T; Kalsi-Ryan S; Kotter M; Kurpad S; Kwon BK; Marino RJ; Martin AR; Massicotte E; Merli G; Middleton JW; Nakashima H; Nagoshi N; Palmieri K; Singh A; Skelly AC; Tsai EC; Vaccaro A; Wilson JR; Yee A; Burns AS
    Global Spine J; 2017 Sep; 7(3 Suppl):231S-238S. PubMed ID: 29164029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials.
    Fawcett JW; Curt A; Steeves JD; Coleman WP; Tuszynski MH; Lammertse D; Bartlett PF; Blight AR; Dietz V; Ditunno J; Dobkin BH; Havton LA; Ellaway PH; Fehlings MG; Privat A; Grossman R; Guest JD; Kleitman N; Nakamura M; Gaviria M; Short D
    Spinal Cord; 2007 Mar; 45(3):190-205. PubMed ID: 17179973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the combination of cellular therapy with stem cells and nanoparticles after a spinal cord injury.
    García E; Sánchez-Noriega S; González-Pacheco G; González-Vázquez AN; Ibarra A; Rodríguez-Barrera R
    Front Neurol; 2023; 14():1127878. PubMed ID: 37181563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the potential of RhoA inhibitors to improve exercise-recoverable spinal cord injury: A systematic review and meta-analysis.
    Luo M; Li YQ; Lu YF; Wu Y; Liu R; Zheng YR; Yin M
    J Chem Neuroanat; 2021 Jan; 111():101879. PubMed ID: 33197553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study.
    Yang Y; Pang M; Du C; Liu ZY; Chen ZH; Wang NX; Zhang LM; Chen YY; Mo J; Dong JW; Xie PG; Wang QY; Liu B; Rong LM
    Cytotherapy; 2021 Jan; 23(1):57-64. PubMed ID: 33218835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.